Health IT

A $1.6M mobile dental clinic in Ottawa is more than a local grant; it's a key test of Canada's new, two-pronged strategy to operationalize health equity.

Pluri is moving its advanced cell-expansion tech from the lab to the lucrative U.S. aesthetics market. Is this a savvy commercial pivot or a risky gamble?

New research reveals systemic failures in disability inclusion are costing Canada's economy. The fix isn't just policy—it's a complete system upgrade.

Aethlon Medical's upcoming financial report is more than a balance sheet; it's a test of viability for its revolutionary Hemopurifier blood filter.

New reports reveal hospitals are squeezed by persistent drug shortages and rising insider data threats, exposing a systemic failure of reactive, manual operations.

Amidst soaring HIV rates and public health emergencies, a new campaign shows why top-down solutions fail and community-led resilience is the only way forward.

With positive FDA feedback and an innovative digital trial design, Herantis Pharma's HER-096 moves closer to becoming a potential disease-modifying therapy.

A new study reveals molecular and AI-imaging tests provide distinct clues for Parkinson's, championing a dual-biomarker approach for earlier, more accurate diagnosis.

A breakthrough in cardiac fibrosis treatment reveals more than a new drug; it signals a systemic shift. How AI and human 'organoids' are making animal models obsolete.

As enterprises drown in a sea of collaboration tools, a new wave of automation promises to restore order. Akkadian Labs is betting on a cure for complexity.

Hannah Cranston Media's spot on Inc.'s Best Workplaces list is more than an HR win. It's a masterclass in turning employee-first policies into a powerful commercial advantage.

While competitors build complex apps, Maxwell TEC is winning the home care market with simple SMS. Their milestone is a strategic signal for patient engagement.

A new startup, morph, is embedding intelligence into materials themselves. This isn't just another app—it's a systemic shift rewriting the rules of industry.

With FDA backing for its novel drug HER-096, a Finnish biotech is advancing a therapy that could finally move beyond symptoms to modify Parkinson's progression.

A $1.6M grant to a local college reveals a deeper strategy: leveraging community partnerships to fix the foundational cracks in Canada's healthcare system.

With a $50 million launch, Peterson Health Analytics aims to give employers the data weapon they've lacked to fight the soaring costs of American healthcare.

A Japanese firm has achieved a breakthrough in manufacturing ultra-smooth capillary tubes, a tiny component set to unlock major advances in medicine and tech.

A new partnership is turning employee health into environmental action, linking steps and workouts to tree planting and ocean cleanup. Is this the future of corporate responsibility?

OneAdvanced is embedding AI into the UK's most regulated sectors. But can a system built on governance and trust truly fix our overburdened services?

With a seasoned drug developer at the helm, preclinical biotech FundaMental Pharma signals a major push to bring its novel TRD therapy through the clinical gauntlet.